Journal profile · Medicine-Pathology and Forensic Medicine
Acta Neuropathologica Communications
ISSN 2051-5960 · BioMed Central · United Kingdom · Founded 2013
Acta Neuropathologica Communications: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 6.47; fully open access; APC about USD 3,890; median 109 days to acceptance (110 articles, last 24 months); 291 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Acta Neuropathologica Communications is published by BioMed Central and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Alzheimer's disease research and treatments, Glioma Diagnosis and Treatment and Neuroinflammation and Neurodegeneration Mechanisms, together about 34.7% of its articles. Its main subfields are Neurology. (generated from OpenAlex topic counts and CAS ranking data)
Acta Neuropathologica Communications (ANC) publishes articles on mechanisms of neurological disease based on experimental or human tissues using molecular, cellular and morphological techniques.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pathology and Forensic Medicine
Editor-in-chief Panteleimon GiannakopoulosPublisher website
Editorial board by country: 3 in mainland China (about 8%); most named United States 12, United Kingdom 4, Mainland China 3, Japan 3, France 3 (38 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Alzheimer's disease research and treatmentsMedicine15.9%
- Glioma Diagnosis and TreatmentMedicine10.3%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience8.5%
- Parkinson's Disease Mechanisms and TreatmentsMedicine8.1%
- Amyotrophic Lateral Sclerosis ResearchMedicine7.7%
- Genetic Neurodegenerative DiseasesNeuroscience4.3%
- Prion Diseases and Protein MisfoldingBiochemistry, Genetics and Molecular Biology3.8%
- Dementia and Cognitive Impairment ResearchMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Neurosciences | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Neurosciences | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Neurosciences | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.47LetPub ·
- Impact factor (publisher) 2025
- 6.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 7Publisher website ·
- CiteScore 2026-06
- 9.3LetPub ·
- SJR 2026-06
- 2.47LetPub ·
- SNIP 2026-06
- 1.39LetPub ·
- h-index
- 37LetPub ·
- h-index
- 132OpenAlex ·
- i10-index
- 1,711OpenAlex ·
- 2-year mean citedness
- 5.27OpenAlex ·
- Self-citation rate
- 3.1%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 273LetPub ·
- Downloads per year (publisher) 2025
- 2,800,000Publisher website ·
Articles by year OpenAlex count · 2,509 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 233 | 233 | 92 |
| 2025 | 291 | 291 | 1,395 |
| 2024 | 205 | 205 | 2,356 |
| 2023 | 208 | 208 | 4,738 |
| 2022 | 190 | 190 | 5,641 |
| 2021 | 201 | 201 | 9,321 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
109 daysMedian, submission to acceptance · P25–P75 75 days – 139 days
- Acceptance to online
- median 17 days (110 articles)
- Submission to online
- median 135 days
- Sample
- 110 articles with submission and acceptance dates (564 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to first decision
- 9 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 3,290 / USD 3,890 / GBP 2,990 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,790 / EUR 3,190 / GBP 2,890 | — | — | |
| LetPub | GBP 2,790 / USD 3,590 / EUR 3,090 | Yes | — | |
| Publisher website | GBP 2,990 / USD 3,890 / EUR 3,290 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteArticle types accepted5
- case reportFormatting guidelines for specific article types can be found below. Research Letter to the Editor Methodology Review Case reportLength not stated
- letter to the editorFormatting guidelines for specific article types can be found below. Research Letter to the Editor Methodology Review Case reportLength not stated
- methodologyFormatting guidelines for specific article types can be found below. Research Letter to the Editor Methodology Review Case reportLength not stated
- researchFormatting guidelines for specific article types can be found below. Research Letter to the Editor Methodology Review Case reportLength not stated
- reviewFormatting guidelines for specific article types can be found below. Research Letter to the Editor Methodology Review Case reportLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data sharing strongly encouraged or required; deposit in public repositories or include in paper/supporting files; 'Availability of data and materials' section required. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Acta Neuropathologica Communications articles are published open access under a CC BY-NC-ND (Creative Common…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- United Kingdom
- Language
- English
- Founded
- 2013
- ISSN
- 2051-5960
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Acta Neuropathologica Communications
What CAS zone is Acta Neuropathologica Communications in?
In the 2025 upgraded edition of the CAS Journal Ranking, Acta Neuropathologica Communications is in Zone 1 of Medicine, and in Zone 1 of the minor category Neurosciences; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Acta Neuropathologica Communications?
The latest impact factor listed by LetPub is 6.47; CiteScore 9.3, h-index 132.
How long does peer review take at Acta Neuropathologica Communications?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 109 days (interquartile range 75–139 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Acta Neuropathologica Communications based?
Of the 38 board members whose country the journal's board page names, 3 (about 8%) are in mainland China; the countries named most often are United States (12), United Kingdom (4) and Mainland China (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Acta Neuropathologica Communications?
According to LetPub and DOAJ records, Acta Neuropathologica Communications is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE and CAS; that list has not been checked against each database.
Is Acta Neuropathologica Communications open access, and what is the APC?
Acta Neuropathologica Communications is a fully open-access journal. APC about USD 3,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .